David B. Matchar, MD

Articles by David B. Matchar, MD

Does Distance Modify the Effect of Self-Testing in Oral Anticoagulation?

ByAdam J. Rose, MD, MSc,Ciaran S. Phibbs, PhD,Lauren Uyeda, MA,Pon Su, MS,Robert Edson, MA,Mei-Chiung Shih, PhD,Alan Jacobson, MD,David B. Matchar, MD

January 20th 2016

Self-testing of anticoagulation improves outcomes, but is expensive. One might assume it is more helpful for patients living farther from care, but the authors disprove this assumption.

Medicare HMO Penetration and Mortality Outcomes of Ischemic Stroke

ByJohn Bian, PhD,William H. Dow, PhD,David B. Matchar, MD

January 1st 2006

Pharmacoeconomics of Atrial Fibrillation and Stroke Prevention

ByCheryl D. Bushnell, MD, MHS,David B. Matchar, MD

April 1st 2004

A Clinical Decision and Economic Analysis Model of Cancer Pain Management

ByAmy P. Abernethy, MD,Gregory P. Samsa, PhD,David B. Matchar, MD

October 1st 2003

Disease Management in Healthcare Organizations: Results of In-Depth Interviews with Disease Management Decision Makers

ByDavid J. Whellan, MD,Elizabeth J. Cohen, MBA,David B. Matchar, MD,Robert M. Califf, MD

July 1st 2002

Latest Updated Articles

Does Distance Modify the Effect of Self-Testing in Oral Anticoagulation?
Published: January 20th 2016 | Updated:
Disease Management in Healthcare Organizations: Results of In-Depth Interviews with Disease Management Decision Makers
Published: July 1st 2002 | Updated:
Medicare HMO Penetration and Mortality Outcomes of Ischemic Stroke
Published: January 1st 2006 | Updated:
Pharmacoeconomics of Atrial Fibrillation and Stroke Prevention
Published: April 1st 2004 | Updated:
A Clinical Decision and Economic Analysis Model of Cancer Pain Management
Published: October 1st 2003 | Updated:

David B. Matchar, MD

Articles by David B. Matchar, MD

Does Distance Modify the Effect of Self-Testing in Oral Anticoagulation?

Medicare HMO Penetration and Mortality Outcomes of Ischemic Stroke

Pharmacoeconomics of Atrial Fibrillation and Stroke Prevention

A Clinical Decision and Economic Analysis Model of Cancer Pain Management

Disease Management in Healthcare Organizations: Results of In-Depth Interviews with Disease Management Decision Makers

Latest Updated Articles

Trending on AJMC

Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration

FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development

Boosting RSV Vaccination in Older Adults Could Save Thousands

Cancer Care in Transition: Navigating Breakthrough Therapies Amid Economic Strain

Real-World Data Key to Optimizing CAR T-Cell Therapy Delivery, Outcomes